Open AccessOpen-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancer
Author(s) -
Gilles Freyer,
Benoît You,
Stéphanie Villet,
Sophie Tartas,
Cécile Fournel-Federico,
Véronique TrilletLenoir,
Salima Hamizi,
Olivier Colomban,
Nathalie Chavernoz,
Claire Falandry
Publication year - 2014
Publication title -
homeopathy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 38
eISSN - 1476-4245
pISSN - 1475-4916
DOI - 10.1016/j.homp.2014.06.001
Subject(s) - medicine , quality of life (healthcare) , depression (economics) , hospital anxiety and depression scale , anxiety , cancer , performance status , surgery , psychiatry , nursing , economics , macroeconomics
Patients with advanced metastatic disease are often treated aggressively with multiple lines of chemotherapy, even in the last month of life. The benefit of such an approach remains uncertain. The objective of the study was to investigate whether Ruta graveolens 9c homeopathic medicine can improve quality of life (QoL) and tumour progression in patients with advanced cancer.